Exopharm™ & Exomere™
Exopharm is an Australian-based company focused on the manufacture and commercialisation of therapeutic exosomes/extracellular vesicles – including adult stem cell derived vesicles.
Exopharm’s patent applied for technology to isolate and purify proprietary vesicle products is called LEAP. Vesicles purified by the LEAP process are called Exomeres.
This is a further advance in Exopharm’s positioning as an international leader and brand in the use of therapeutic exosomes/extracellular vesicles for regenerative medicine.
More information at www.exopharm.com